Wang

Wang v. Zymergen Inc.

Good Law
United States District Court, Northern District of CaliforniaDecember 20, 20215:21-cv-06028California642 words

Opinion

Trial Court Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA 6 HARIRAM SHANKAR, Case No. 21-cv-06028-JD

Plaintiff,

ORDER RE LEAD PLAINTIFF AND

v. LEAD COUNSEL

ZYMERGEN INC., et al., Defendants.

This is a securities class action against Zymergen Inc. and other defendants. The action was filed on behalf of persons and entities who purchased or otherwise acquired Zymergen common stock issued in connection with the company’s April 2021 initial public offering. Before the Court are competing motions for lead plaintiff and lead counsel appointment. I. APPOINTMENT OF LEAD PLAINTIFF The Court has discussed in other orders the three-step process for appointing a lead plaintiff under the Private Securities Litigation Reform Act (“PSLRA”), 15 U.S.C. § 78u- 4(a)(3)(B). See In re Stitch Fix, Inc. Securities Litigation, 393 F. Supp. 3d. 833 (N.D. Cal. 2019). The first step is for the plaintiff in the first-filed action to “publiciz[e] the pendency of the action, the claims made and the purported…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.